Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications

Karim Rihawi1, Angela Dalia Ricci1, Alessandro Rizzo1

  • 1Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138 Bologna, Italy.

Insights

Gastric cancer is a leading cause of cancer death. Targeting the tumor microenvironment, including inflammatory cells, shows promise for overcoming treatment resistance and improving outcomes in gastric cancer patients.

Area of Science:

  • Oncology
  • Cancer Biology
  • Immunology

Background:

  • Gastric cancer (GC) is a globally prevalent malignancy with a poor prognosis, particularly in advanced stages.
  • Despite treatment advances, GC exhibits significant resistance to various therapeutic modalities.
  • Identifying novel therapeutic targets is crucial for improving patient outcomes.

Purpose of the Study:

  • To provide an overview of the inflammatory tumor microenvironment (TME) in gastric cancer.
  • To highlight the role of tumor-associated cells within the GC TME.
  • To discuss the implications of the inflammatory TME for future therapeutic strategies.

Main Methods:

  • Literature review of existing evidence on the inflammatory TME in GC.
  • Analysis of tumor-associated cells and their functions within the GC microenvironment.
  • Synthesis of findings to inform future therapeutic development.

Main Results:

  • The TME plays a critical role in GC progression and resistance to therapy.
  • Various inflammatory cells within the TME influence cancer development and treatment response.
  • Understanding these cellular interactions is key to developing effective therapies.

Conclusions:

  • The inflammatory TME is a significant factor in gastric cancer pathogenesis and drug resistance.
  • Targeting specific components of the inflammatory TME presents a promising avenue for novel GC therapies.
  • Further research into TME-targeted strategies is warranted to improve clinical outcomes.